Clinical Trials on Psoriasis Arthropathica in Belgium
Total 146 results
-
Cliniques universitaires Saint-Luc- Université...AmgenCompletedPsoriatic ArthritisBelgium
-
Cliniques universitaires Saint-Luc- Université...University Hospital, Ghent; Janssen-Cilag International NVCompletedPsoriatic ArthritisBelgium
-
PfizerCompletedArthritis, PsoriaticBelgium
-
PfizerCompleted
-
University Hospital, GhentUniversity GhentCompleted
-
University Hospital, GhentRecruitingPsoriasis VulgarisBelgium
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Galapagos NVCompletedPsoriatic ArthritisEstonia, Belgium, Bulgaria, Czechia, Poland, Spain, Ukraine
-
Eli Lilly and CompanyCompletedPsoriasis, ArthriticUnited States, Spain, Russian Federation, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Japan, Mexico, Netherlands, Poland, Ukraine, United Kingdom
-
Galapagos NVTerminatedPsoriatic ArthritisEstonia, Belgium, Bulgaria, Czechia, Poland, Spain, Ukraine
-
ACELYRIN Inc.CompletedPsoriatic ArthritisPoland, Hungary, Germany, Belgium, Czechia, Austria, Spain
-
AmgenCompleted
-
University Hospital, GhentBelgium Health Care Knowledge CentreNot yet recruiting
-
University Hospital, GhentKU LeuvenCompleted
-
AmgenCompletedPsoriatic ArthritisBelgium, Canada, United Kingdom, Germany, Netherlands
-
LEO PharmaCompletedPsoriasis of ScalpFrance, Canada, Belgium, Denmark, Sweden
-
University Hospital, GhentRecruitingPsoriasis VulgarisBelgium
-
University Hospital, GhentKU Leuven; University GhentRecruitingPsoriasis VulgarisBelgium
-
University Hospital, GhentKU Leuven; University GhentCompletedPsoriasis VulgarisBelgium
-
University Hospital, GhentKU Leuven; University GhentCompletedPsoriasis VulgarisBelgium
-
University Hospital, GhentKU Leuven; University GhentCompletedPsoriasis VulgarisBelgium
-
AmgenCompletedPsoriatic ArthritisSpain, Belgium, Denmark, United States, Germany, Russian Federation, Austria, United Kingdom, Canada, Italy, Switzerland
-
PfizerCompletedPsoriasis | Psoriatic ArthritisBelgium, Denmark, France, Canada, Hungary, Germany, United States
-
Sun Pharmaceutical Industries LimitedActive, not recruitingActive Psoriatic ArthritisUnited States, Australia, Czechia, Germany, India, Japan, Korea, Republic of, Poland, Spain
-
PfizerRecruitingPsoriatic ArthritisIsrael, France, Spain, Finland, Netherlands, Belgium, Denmark, Sweden
-
University Hospital, GhentKU Leuven; University GhentTerminated
-
AmgenRecruitingActive Juvenile Psoriatic ArthritisSpain, Turkey, Belgium, France, Greece, Italy, United Kingdom, Austria, Germany, Netherlands, Poland, Romania, Lithuania, South Africa, Portugal
-
Bristol-Myers SquibbTerminatedPsoriatic ArthritisArgentina, France, Italy, United States, Canada, Belgium, Netherlands, Australia, Germany, South Africa, Spain, Norway
-
Gilead SciencesGalapagos NVTerminatedPsoriatic ArthritisKorea, Republic of, United States, Australia, Belgium, Canada, Czechia, Hungary, Japan, Poland, Spain, Taiwan
-
LEO PharmaCompletedPsoriasis VulgarisBelgium, Canada, France, Germany, Netherlands, Spain, United Kingdom
-
University Hospital, GhentNovartis; Janssen, LP; Vlerick Business School; Scientific Research Foundation-FlandersRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
University Hospital, GhentCompleted
-
LEO PharmaCompletedPsoriasis of ScalpCanada, Belgium, Finland, France, Germany, Netherlands, United Kingdom
-
AbbVieActive, not recruitingPsoriatic Arthritis (PsA)United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, South Africa, Spain, Sweden, United...
-
AmgenCompletedPhase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisPsoriasis | Psoriatic ArthritisUnited States, Canada, United Kingdom, Australia, Hungary, Belgium, Netherlands, Germany, Czechia, Estonia, Latvia
-
Sun Pharmaceutical Industries LimitedRecruitingActive Psoriatic ArthritisUnited States, Australia, Czechia, Estonia, Korea, Republic of, Poland, Slovakia, Spain, Taiwan, Germany, Italy, India, Canada
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisGermany, Netherlands, Spain, Argentina, Belgium, Colombia, Italy, United States, United Kingdom, Ireland, France, Mexico, Canada, Austria, Czechia, Hungary, Norway
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisGermany, United Kingdom, Belgium, United States, Australia, Thailand, Russian Federation, Czechia, Canada, Poland, Puerto Rico
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisUnited Kingdom, Belgium, Germany, Thailand, Israel, United States, Philippines, Singapore, Italy, Argentina, Russian Federation, Bulgaria, Czechia, Australia, Canada, Poland, Brazil, Slovakia
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisGermany, United Kingdom, United States, Belgium, Philippines, Singapore, Thailand, Brazil, Czech Republic, Italy, Argentina, Israel, Russian Federation, Bulgaria, Romania, Australia, Canada, Poland, Slovakia
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Poland, Russian Federation, Spain, United Kingdom
-
PfizerCompletedPsoriatic ArthritisUnited States, Canada, Spain, Germany, Australia, Hungary, Belgium, Mexico, Poland, Russian Federation, Taiwan, United Kingdom, Slovakia, Czechia, Bulgaria, France
-
Radboud University Medical CenterUniversity Hospital, Ghent; ZonMw: The Netherlands Organisation for Health... and other collaboratorsActive, not recruitingPsoriasis | Psoriasis VulgarisNetherlands, Belgium
-
UCB Biopharma SRLActive, not recruitingPsoriatic ArthritisUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Poland, Russian Federation, Spain, United Kingdom
-
PfizerCompletedTofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors (OPAL BEYOND)Psoriatic ArthritisUnited States, Belgium, Spain, Taiwan, Australia, Brazil, Czechia, France, Germany, Mexico, Poland, Russian Federation, Slovakia, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingPsoriatic ArthritisUnited States, Australia, Belgium, Spain, Argentina, China, Canada, Colombia, Czechia, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Taiwan, United Kingdom
-
Eli Lilly and CompanyCompletedPsoriatic ArthritisBelgium, Hungary, Canada, India, Israel, Italy, Australia, Netherlands, United Kingdom, Mexico, Switzerland, South Africa, Poland, Finland, Argentina, France, Germany, Ukraine, Spain, Austria, Denmark, Sweden
-
Novartis PharmaceuticalsCompletedAxial Psoratic ArthritisBelgium, Israel, Spain, Switzerland, Greece, Italy, Bulgaria, Germany, Hungary, Estonia, United Kingdom, Poland, France, Czechia, Russian Federation, Romania, Ireland, Finland
-
AmgenCompletedPsoriatic ArthritisUnited States, Italy, Belgium, France, Canada, Taiwan, United Kingdom, Czechia, Russian Federation, Hungary, Germany, Bulgaria, Estonia, South Africa, Poland, Spain